Hypertrophic & Keloid Scar Treatment Market (By Scar Type: Hypertrophic, Keloid; By Product: Topical Products [Silicone Sheets, Creams, Gels, Other], Laser products [Pulse-dyed, CO2, Others], Injectable, Others; By End-user: Hospitals, Clinics, Retail Pharmacies/E-commerce) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction

The global hypertrophic & keloid scar treatment market size is projected to around USD 10.5 billion by 2026, the market is projected to grow with 10.0% CAGR during the forecast time frame. The market is driven by rising consciousness about aesthetic appearance.

Scar treatment delivers complete skin rejuvenation, therefore improving aesthetic appeal. The need for aesthetic products mostly exists among women, due to which they are the major consumers of these products. Also, increase in the numeral of road accidents and burn cases has also influenced the development of the hypertrophic and keloid scar treatment market.

Market Dynamics

Increase in consciousness regarding esthetic appeal has led to the market development. As per Plastic Surgery Statistics Report, around 182,321 reconstructive processes for scar revision were performed in 2017. Henceforth, the need for reconstructive processes also plays a significant role in boost up the market development.

Market Insights

Increase in burn injury cases has also led to augmented need for hypertrophic and keloid scar treatments. Plastic surgeries or resurfacing laser therapies are usually performed to eliminate these marks. Hypertrophic burn marks can affect a victim’s appearance and are related with other conditions, for instance, contractures and pruritis.

The introduction of technically advanced products, for instance, laser therapies, will also support industry growth. These products assistance reduce scars caused owing to trauma injuries, burns, and surgery. For example, Non-ablative laser therapy destroys scar tissues through vascularization with the aid of a pulsed dye laser. Though, exorbitant prices of laser products are expected to hamper the market development.

Market Segmentation

Market By Scar Type

• Hypertrophic
• Keloid

Market By Product

• Topical Products
  • Silicone Sheets
  • Creams
  • Gels
  • Others
• Laser products
  • Pulse-dyed
  • CO2
  • Others
• Injectable
• Others

Market By End-user

• Hospitals
• Clinics
• Retail Pharmacies/E-commerce

Market By Geography

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Rest of MEA

Regional Insights

In 2018, North America captures the largest market share and is expected to observer steady growth during the forthcoming years. High prevalence of skin-related disorders, burn injuries, and trauma are among the main factors accountable for the market growth. Furthermore, accessibility and acceptance of progressive treatment options, for instance, laser treatments, are projected to support the development.Asia Pacific is expected to observer the fastest CAGR over the forecast time frame due to obtainability of technically progressive products and occurrence of a large numeral of producers in nations, for instance, China. Accessibility of laser instruments at cheaper prices in developing countries has increased their acceptance, thus pushing market growth. Due to high incidence of burn injuries, India has also backed considerably to the region’s development.

Market Participants

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the Hypertrophic & keloid scar treatment market are Sonoma Pharmaceuticals, Inc., Lumenis Ltd., Suneva Medical, Inc., Smith & Nephew PLC, Mölnlycke Health Care AB, Cynosure, Inc., and Enaltus, LLC.